Pretax income is the income that a company earns before paying income taxes. Eli Lilly and Co's pretax income for the
three
months ended in Dec. 2024 was $5,039 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $12,680 Mil.
Eli Lilly and Co's pretax margin was 37.23%.
During the past 13 years, Eli Lilly and Co's highest Pretax Margin was 29.46%. The lowest was 11.54%. And the median was 20.48%.
Eli Lilly and Co Pre-Tax Income Historical Data
The historical data trend for Eli Lilly and Co's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eli Lilly and Co's Pre-Tax Income
For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eli Lilly and Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Eli Lilly and Co's Pre-Tax Income falls into.
Eli Lilly and Co Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Eli Lilly and Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,680 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eli Lilly and Co (NYSE:LLY) Pre-Tax Income Explanation
Eli Lilly and Co's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Eli Lilly and Co's highest Pretax Margin was 29.46%. The lowest was 11.54%. And the median was 20.48%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eli Lilly and Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Eli Lilly and Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LLY has been successfully added to your 